A Proof of Principle Study of Ondansetron for the Prevention of Vasovagal Syncope: The Eleventh Prevention of Syncope Trial (POST11)
Conditions:   Vasovagal Syncope (VVS);   Syncope Interventions:   Drug: Ondansetron;   Drug: Placebo Sponsor:   University of Calgary Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials